Tumor suppressor protein Pdcd4 interacts with Daxx and modulates the stability of Daxx and the Hipk2-dependent phosphorylation of p53 at serine 46
Open Access
- 14 January 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogenesis
- Vol. 2 (1), e37
- https://doi.org/10.1038/oncsis.2012.37
Abstract
The tumor suppressor protein Pdcd4 is a nuclear/cytoplasmic shuttling protein that has been implicated in the development of several types of human cancer. In the nucleus, Pdcd4 affects the transcription of specific genes by modulating the activity of several transcription factors. We have identified the Daxx protein as a novel interaction partner of Pdcd4. Daxx is a scaffold protein with roles in diverse processes, including transcriptional regulation, DNA-damage signaling, apoptosis and chromatin remodeling. We show that the interaction of both proteins is mediated by the N-terminal domain of Pdcd4 and the central part of Daxx, and that binding to Pdcd4 stimulates the degradation of Daxx, presumably by disrupting the interaction of Daxx with the de-ubiquitinylating enzyme Hausp. Daxx has previously been shown to serve as a scaffold for protein kinase Hipk2 and tumor suppressor protein p53 and to stimulate the phosphorylation of p53 at serine 46 (Ser-46) in response to genotoxic stress. We show that Pdcd4 also disrupts the Daxx–Hipk2 interaction and inhibits the phosphorylation of p53. We also show that ultraviolet irradiation decreases the expression of Pdcd4. Taken together, our results support a model in which Pdcd4 serves to suppress the phosphorylation of p53 in the absence of DNA damage, while the suppressive effect of Pdcd4 is abrogated after DNA damage owing to the decrease of Pdcd4. Overall, our data demonstrate that Pdcd4 is a novel modulator of Daxx function and provide evidence for a role of Pdcd4 in restraining p53 activity in unstressed cells.Keywords
This publication has 73 references indexed in Scilit:
- The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML networkNature, 2008
- The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2–DAXX–HAUSP complexThe EMBO Journal, 2008
- Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalizationBiochemical Society Transactions, 2007
- Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor ProteinCancer Research, 2005
- Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses TumorigenesisCancer Research, 2005
- Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosisOncogene, 2004
- Daxx Silencing Sensitizes Cells to Multiple Apoptotic PathwaysMolecular and Cellular Biology, 2003
- Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformationProceedings of the National Academy of Sciences, 1999
- Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse developmentGenes & Development, 1999
- Daxx, a Novel Fas-Binding Protein That Activates JNK and ApoptosisCell, 1997